[PDF] Top 20 Clinical Performance of the PreTect HPV Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer
Has 10000 "Clinical Performance of the PreTect HPV Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer" found on our website. Below are the top 20 most common "Clinical Performance of the PreTect HPV Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer".
Clinical Performance of the PreTect HPV Proofer E6/E7 mRNA Assay in Comparison with That of the Hybrid Capture 2 Test for Identification of Women at Risk of Cervical Cancer
... The PreTect HPV-Proofer assay (Proofer; Norchip AS, Nor- way) is a type-specific E6/E7 mRNA-based test for oncogenic types 16, 18, 31, 33, and 45, with both ... See full document
7
Aptima HPV E6/E7 mRNA Test Is as Sensitive as Hybrid Capture 2 Assay but More Specific at Detecting Cervical Precancer and Cancer
... (HPV) E6/E7 oncogene expression may be more predictive of cervical cancer risk than testing for HPV ...Aptima HPV test (Gen-Probe) detects ... See full document
8
Performance of the Aptima High Risk Human Papillomavirus mRNA Assay in a Referral Population in Comparison with Hybrid Capture 2 and Cytology
... Incorporated) assay, which detects E6/E7 mRNA from 14 high-risk types, the Hybrid Capture 2 HPV DNA (HC2; Qiagen Incorpo- rated) test, and repeat ... See full document
6
Presence of E6 and E7 mRNA from Human Papillomavirus Types 16, 18, 31, 33, and 45 in the Majority of Cervical Carcinomas
... genes E6 and E7 is well established and a source of interest with regard to HPV testing for cervical ...invasive cervical squamous cell carcinomas (SCCs) in which we evaluated the ... See full document
8
Cytology and Human Papillomavirus Testing 6 to 12 Months after ASCUS or LSIL Cytology in Organized Screening To Predict High Grade Cervical Neoplasia between Screening Rounds
... the performance of human papillomavirus (HPV) E6/E7 mRNA (PreTect HPV- Proofer; NorChip, Klokkarstua, Norway) and DNA (Amplicor HPV test; Roche ... See full document
9
Performance of Human Papillomavirus DNA and mRNA Testing Strategies for Women with and without Cervical Neoplasia
... and E6/E7 mRNA from high-risk human papillomavirus (HPV) types in 643 women with high-grade cervical neoplasia (135 cases of cervical intraepithelial neoplasia ... See full document
7
MassARRAY Spectrometry Is More Sensitive than PreTect HPV Proofer and Consensus PCR for Type Specific Detection of High Risk Oncogenic Human Papillomavirus Genotypes in Cervical Cancer
... better risk stratification and clinical management of women testing positive for HPV and for epidemiologic ...oncogenic HPV types: HPV-16, -18, -31, -33, -35, -39, -45, -51, -52, ... See full document
8
Type Specific Human Papillomavirus E6/E7 mRNA Detection by Real Time PCR Improves Identification of Cervical Neoplasia
... HR- HPV DNA detection but only a few based on detection of oncogenic ...high-grade cervical intraepithelial neoplasia (CIN) and have been shown to be a valuable tool in triage of atypical squamous cells of ... See full document
6
Sensitivity, Specificity, and Clinical Value of Human Papillomavirus (HPV) E6/E7 mRNA Assay as a Triage Test for Cervical Cytology and HPV DNA Test
... (HPV) E6/E7 mRNA is more specific than testing for HPV ...the performance of the PreTect HPV-Proofer E6/E7 mRNA assay (Norchip) ... See full document
8
Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population Based Cervical Cancer Screening
... next-generation HPV assay designed to detect a pool of 12 carcinogenic HPV genotypes in aggregate, with concurrent, separate detection of HPV16 and ...the clinical performance of ... See full document
9
Comparison of Seven Tests for High Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears: the Predictors 2 Study
... the identification of high-grade cervical intraepithelial neoplasia ...new HPV tests are now available for this purpose, and a direct comparison of their properties is ...1,099 women ... See full document
7
Comparison of Clinical Performance of Abbott RealTime High Risk HPV Test with That of Hybrid Capture 2 Assay in a Screening Setting
... the clinical accuracy of the Abbott RealTime HR HPV test with a clini- cally validated reference HPV test, hybrid capture 2, on sam- ples from women enrolled ... See full document
6
Comparison of the Third Wave Invader Human Papillomavirus (HPV) Assay and the Digene HPV Hybrid Capture 2 Assay for Detection of High Risk HPV DNA
... detection E6/E7 mRNA, and the Third Wave Invader HPV assay (Third Wave Technologies, Madison, WI) (13, 22) are currently under investigation as alternative technologies for HPV ... See full document
6
High Risk Human Papillomavirus (hrHPV) E6/E7 mRNA Testing by PreTect HPV Proofer for Detection of Cervical High Grade Intraepithelial Neoplasia and Cancer among hrHPV DNA Positive Women with Normal Cytology
... DNA-positive women were subsequently subjected to hrHPV mRNA analysis by PreTect HPV-Proofer (mRNA ...invalid mRNA test result ...and E6/E7 ... See full document
7
Human papilloma virus E6/E7 messenger RNA as a biomarker for detecting the risk evaluation of cervical cancer progression: overview of recent clinical trials
... 105 HPV DNA-infected women with abnormal Pap smear test were undergone a study by Salimovi´c-Beˇsi´ et ...and E6/E7 mRNA based assays for detection of HPV-16, 18, 31, 33, ... See full document
11
Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results
... of cervical cancer is strongly associated with the presence of persistent high-risk (HR) human papillomavirus (HPV) ...(LA) HPV tests have become available for HPV ...their ... See full document
8
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture
... the hybrid capture assay, we tabulated the joint results from the three laboratories compared with those of the original HPV DNA reference ...the assay would be, in aggregate, if it was ... See full document
6
THE CARCINOGENIC POTENTIAL OF E6 & E7 GENES OF HIGH RISK HPV COMPARED WITH E6, E7 GENES OF LOW RISK HPV IN HUMAN CERVICAL CANCER: A REVIEW
... The HPV Genome - key players: The circular HPV DNA is 6800 to 8000 base pairs in length and codes for eight genes - E6, E7, E1, E2, E4, E5, L1 and ...oncogenesis. E6 and E7 genes ... See full document
10
Comparison of peptide enzyme linked immunosorbent assay and radioimmunoprecipitation assay with in vitro translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins
... We compared two assays, a radioimmunoprecipitation assay with in vitro-translated HPV-16 E6 and E7 proteins and an enzyme-linked immunosorbent assay ELISA with E6 and E7 synthetic peptid[r] ... See full document
5
Original Article Risk evaluation of cervical cancer progress by screening human papillomavirus DNA, E6/E7 mRNA and protein, and cell free ferrous protoporphyrin
... of cervical cancer. We sought to evaluate the ef- ficiency of HPV DNA, E6/E7 mRNA and protein, and cell free ferrous protoporphyrin (FH) tests for cervical cancer ... See full document
8
Related subjects